Skip to main content
PHAXIAM Therapeutics S.A. (PHXM)
Mar 11, 2024 - PHXM was delisted
3.100
-0.170 (-5.20%)
Last trade price

PHAXIAM Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current20222021202020192018201720162015
Market Capitalization
291062166132122376--
Market Cap Growth
--83.52%-62.48%25.15%8.89%-67.66%---
Enterprise Value
18-175314566-31156-37-49
PE Ratio
-1.91-42.21-1.02-1.85-1.88-2.76-9.34--
PS Ratio
4.400.3113.0836.5222.2923.7793.08--
PB Ratio
0.720.412.395.121.380.731.73--
P/FCF Ratio
-0.941.66-0.96-2.57-1.86-1.98-11.87--
P/OCF Ratio
-0.95-0.30-0.96-2.63-2.72-2.21-12.67--
EV/Sales Ratio
2.73-0.5011.0931.9511.11-5.9938.74-8.41-15.34
EV/EBITDA Ratio
-0.88-2.49-1.01-1.89-1.030.71-4.371.623.06
EV/EBIT Ratio
-0.84-9.41-0.91-1.75-0.960.70-4.291.593.00
EV/FCF Ratio
-0.51-2.70-0.81-2.25-0.930.50-4.941.803.03
Debt / Equity Ratio
0.410.581.111.030.170.010.020.080.02
Debt / EBITDA Ratio
-1.142.16-0.56-0.44-0.25-0.05-0.10-0.13-0.05
Debt / FCF Ratio
-0.662.35-0.44-0.52-0.22-0.04-0.11-0.15-0.05
Quick Ratio
1.463.331.691.513.686.5115.995.978.19
Current Ratio
1.783.652.001.694.107.2616.516.709.24
Asset Turnover
0.090.550.060.040.040.020.030.08-
Interest Coverage
-14.511.21-18.91-12.69-39.87-1364.07-9.54-311.90-233.62
Return on Equity (ROE)
-38.60%-1.00%-217.90%-130.80%-54.20%-23.40%-30.90%-52.90%-
Return on Assets (ROA)
-17.30%-0.40%-73.10%-73.70%-43.80%-21.10%-27.90%-44.70%-
Return on Capital (ROIC)
-29.53%5.87%-117.20%-127.50%-64.28%-29.55%-16.76%-58.15%-32.57%
Earnings Yield
-43.36%-2.37%-98.39%-53.98%-53.21%-36.16%-10.71%--
FCF Yield
-87.32%60.06%-104.38%-38.87%-53.86%-50.60%-8.42%--
Buyback Yield / Dilution
-54.65%-17.32%-47.37%--0.01%-5.12%---
Total Shareholder Return
-54.65%-17.32%-47.37%--0.01%-5.12%---
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).